Do NAD boosters really deplete your methyl groups?

What did @drtylerpanzner actually say?

The claim is that supplementing NAD, NMN, or NR forces your body's methylation system to work overtime recycling NAD, leaving fewer methyl groups available for other functions. As he put it, your body "may not have enough methyl groups to do other good things," like making neurotransmitters, producing antioxidants, or running detox pathways. He recommends pairing these supplements with methyl donors, SAM-e, trimethylglycine (TMG), or methylfolate, and monitoring homocysteine as a warning signal. The video stops short of telling you to avoid NAD entirely. It frames the whole thing as a manageable risk with a practical workaround. That's a more measured take than most longevity-space content, and it deserves credit for that, even if some of the underlying biochemistry needs scrutiny.

Does the science back this up?

The methylation burden idea is real, but the evidence in humans is thinner than the confident framing suggests. The mechanism he describes is accurate in outline: NMN and NR are metabolized through pathways that generate N-methylnicotinamide (MNAM), a process that consumes S-adenosylmethionine (SAM), the body's primary methyl donor. This is documented. Trammell et al. (2016, Nature Communications) confirmed that NR supplementation in humans increases MNAM production, which does consume SAM. The concern about downstream methylation competition is therefore not invented.

However, whether this actually depletes methyl groups enough to raise homocysteine or impair neurotransmitter synthesis in healthy adults taking typical doses is a different question. Human trials of NR and NMN, including Martens et al. (2020, Nature Aging) and Yoshino et al. (2021, Science), did not report clinically significant homocysteine elevations. Most trials run 8 to 12 weeks, which may not capture longer-term effects. The honest answer is that we don't have long-duration data at moderate to high doses, so "can raise homocysteine over time" is plausible but not yet confirmed in controlled trials.

What did they get wrong (or right)?

He gets the biochemistry directionally right and deserves credit for flagging a real metabolic consideration that most NAD supplement marketing ignores entirely. But the framing could mislead viewers into thinking this is an established risk rather than a theoretical one with limited human evidence.

The phrase "taking NAD for long periods of time can raise that homocysteine" is stated as near-fact. That's an overclaim. The more accurate version is that the mechanism exists and animal data supports concern, but human evidence has not consistently demonstrated this effect. Olsen et al. (2023, Cell Metabolism) found that high-dose NR in mice elevated MNAM significantly, but human extrapolation remains speculative at standard supplement doses.

• What he got right: The MNAM methylation pathway is real and does consume SAM.
• What he got right: Homocysteine is a reasonable biomarker to monitor.
• What he overstated: Homocysteine elevation from typical NAD supplementation in humans is not well-established.
• What he skipped: Individual variation in MTHFR and COMT genotype matters enormously here. Some people metabolize methyl donors very differently.

What should you actually know?

If you're taking NMN or NR, the methylation angle is worth understanding, not panicking over. The suggestion to pair these supplements with TMG or methylfolate is a reasonable precaution and is supported by plausible biochemistry, though controlled trials specifically testing this combination are sparse. If you already have an MTHFR variant or a history of elevated homocysteine, this conversation with a clinician becomes more relevant, not less.

Homocysteine testing is genuinely useful here, and it's inexpensive. That's practical, evidence-adjacent advice. But anyone watching this video should know that the risk he describes is currently more theoretical than proven in humans at normal supplement doses. The supplement industry's NAD marketing is almost uniformly overconfident. This video is a more honest counterpoint, but it drifts toward treating a plausible hypothesis as established fact. Talk to a clinician who knows your full picture before adding methyl donors to your stack.